Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09
Original SEC Filing: Click here
Webplus: SKBI/20091209/8-K/2_EX-99.1/000.htm SEC Original: v168568_ex99-1.htm
Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology todressmpany-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI’AN, CHINA, December 9 , 2009ystar Bio-Pharmaceuticalmpanyystar will manufacture its aquaculture vaccine in its new 51,000 square
Webplus: SKBI/20091209/8-K/1/000.htm SEC Original: v168568_8k.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): December 9, 2009YSTAR BIO-PHARMACEUTICALMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China
Company Information:
Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.